⸺ Celvora
KLOW
Research blend combining KPV, BPC-157, TB-500 and GHK-Cu — studied for inflammation, tissue repair and skin pathways.
Secure checkout. Free shipping on orders over £100.
Independently tested
COA on request
Fast dispatch
Order before 2pm
Research use only
Not for human consumption
⸺ Overview
About KLOW
KLOW combines KPV with BPC-157, TB-500 and GHK-Cu in a single vial.
⸺ Mechanism of Action
How it works
Combined complementary repair and inflammation pathways.
⸺ Research
Areas of study
Inflammation models
KPV describes reduced inflammatory markers.
Soft-tissue repair
BPC-157 and TB-500 improve tissue repair.
Skin and collagen biology
GHK-Cu enhances collagen synthesis.
⸺ Details
Specification
- CAS
- Blend
- Intended use
- Research use only.
- Storage
- Lyophilised: cool, dry.
- Solubility
- Vial holds up to 3mL.
- Shelf life
- Lyophilised: 24 months.
- Handling
- Sterile technique.
You might also research
View all →
Retatrutide
Investigational triple receptor agonist targeting GLP-1, GIP and glucagon — studied for appetite control, energy expenditure and glucose balance.
Tirzepatide
Dual GLP-1 and GIP receptor agonist studied in preclinical models for glucose regulation, insulin sensitivity and energy balance.
Semaglutide
Synthetic analogue of the GLP-1 hormone used in research to study glucose regulation, insulin secretion and the incretin response.